• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?

作者信息

da Costa Wilson Luiz, Massarweh Nader N

机构信息

Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.

Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, USA.

出版信息

Ann Surg Oncol. 2021 Jun;28(6):3196-3197. doi: 10.1245/s10434-020-09376-8. Epub 2020 Nov 21.

DOI:10.1245/s10434-020-09376-8
PMID:33221979
Abstract
摘要

相似文献

1
ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?ASO作者反思：胰腺癌患者的多模式治疗：所有人都适合新辅助治疗吗？
Ann Surg Oncol. 2021 Jun;28(6):3196-3197. doi: 10.1245/s10434-020-09376-8. Epub 2020 Nov 21.
2
ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?ASO作者反思：单纯化疗用于胰腺癌的全新辅助治疗？
Ann Surg Oncol. 2024 Sep;31(9):6203-6204. doi: 10.1245/s10434-024-15660-8. Epub 2024 Jun 22.
3
ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence.ASO作者反思：胰腺癌新辅助治疗可能减少微小静脉侵犯，微小静脉侵犯是与肝转移相关的独立预后因素。
Ann Surg Oncol. 2022 Aug;29(8):5003-5004. doi: 10.1245/s10434-022-11662-6. Epub 2022 Apr 5.
4
ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?ASO作者反思：新辅助化疗与可接受的胰腺癌短期预后相关吗？
Ann Surg Oncol. 2021 Apr;28(4):1906-1907. doi: 10.1245/s10434-020-09472-9. Epub 2021 Jan 2.
5
ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer.ASO作者反思：一种新型唾液酸化刘易斯抗原相关肿瘤标志物联合指数增强了对新辅助治疗有适度放射学反应的胰腺癌患者的预测意义。
Ann Surg Oncol. 2024 May;31(5):2971-2972. doi: 10.1245/s10434-024-15021-5. Epub 2024 Feb 16.
6
ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
Ann Surg Oncol. 2018 Dec;25(Suppl 3):810-811. doi: 10.1245/s10434-018-6874-y. Epub 2018 Oct 29.
7
ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.
Ann Surg Oncol. 2021 Nov;28(12):7770-7771. doi: 10.1245/s10434-021-10177-w. Epub 2021 May 24.
8
ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer-Standard of Care or Still Worth Debating?ASO作者反思：胰腺癌新辅助治疗——护理标准还是仍值得商榷？
Ann Surg Oncol. 2020 Apr;27(4):1201-1202. doi: 10.1245/s10434-019-08135-8. Epub 2019 Dec 17.
9
ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
Ann Surg Oncol. 2021 Jul;28(7):3798-3799. doi: 10.1245/s10434-020-09413-6. Epub 2020 Nov 24.
10
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer.ASO作者反思：新辅助化疗转换：优化胰腺癌新辅助治疗顺序
Ann Surg Oncol. 2022 Mar;29(3):1592-1593. doi: 10.1245/s10434-021-11019-5. Epub 2021 Oct 27.